Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 3/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465655 | 0.95 | KEAP1 (0.42) | KEAP1NFE2L2KDM4EMAPK1HIF1A | |
| SCHEMBL19988824 | 0.93 | KEAP1 (0.41) | KEAP1NFE2L2KDM4EMAPK1HIF1A | |
| SCHEMBL465815 | 0.89 | TGFBR1 (0.32) | TGFBR1 | |
| SCHEMBL81704 | 0.84 | KEAP1 (0.58) | KEAP1NFE2L2 | |
| SCHEMBL16803277 | 0.79 | KDM4E (0.37) | KEAP1NFE2L2KDM4EMAPK1HIF1A | |
| SCHEMBL19998248 | 0.79 | KDM4E (0.37) | KEAP1NFE2L2KDM4EMAPK1HIF1A | |
| SCHEMBL907569 | 0.78 | KDM4E (0.52) | KDM4EMAPK1HIF1ATGFBR1 | |
| SCHEMBL632876 | 0.78 | KDM4E (0.46) | KDM4EMAPK1HIF1ATGFBR1 | |
| SCHEMBL14865406 | 0.78 | KDM4E (0.35) | KEAP1NFE2L2KDM4EMAPK1HIF1A | |
| SCHEMBL465638 | 0.77 | TGFBR1 (0.33) | TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12447228-B2 | Polymer particles | TERUMO CORPORATION (JP) | 2025-10-21 | — | — | US | disclosed |
| EP-3518983-B1 | POLYMER PARTICLES | TERUMO CORP (JP) | 2024-04-24 | — | — | EP | disclosed |
| US-20230190991-A1 | POLYMER PARTICLES | TERUMO CORPORATION (JP) | 2023-06-22 | — | — | US | disclosed |
| US-11617814-B2 | Methods of treatment comprising administering polymer particles configured for intravascular delivery of pharmaceutical agents | TERUMO CORPORATION (JP) | 2023-04-04 | — | — | US | disclosed |
| CN-109789222-B | Polymer particles | 泰尔茂株式会社 | 2022-02-25 | — | — | CN | disclosed |
| US-20200324016-A1 | POLYMER PARTICLES | MICROVENTION, INC. | 2020-10-15 | — | — | US | disclosed |
| US-10729805-B2 | Drug delivery polymer particles with hydrolytically degradable linkages | TERUMO CORPORATION (JP) | 2020-08-04 | — | — | US | disclosed |
| US-20190255213-A1 | POLYMER PARTICLES | MICROVENTION, INC. | 2019-08-22 | — | — | US | disclosed |
| EP-3518983-A1 | POLYMER PARTICLES | Terumo Corporation (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-10328175-B2 | Polymer particles | TERUMO CORPORATION (JP) | 2019-06-25 | — | — | US | disclosed |
| WO-2006068852-A1 | SOLVENT RESISTANT IMAGEABLE ELEMENT | EASTMAN KODAK COMPANY (US) | 2006-06-29 | — | — | WO | disclosed |
| US-6969579-B1 | top layer containing a co-polymer of an unsaturated compound containing an imide group and a comonomer selected from an acryl imides, acrylonitriles, acryalmides and acrylic acids; chemical resistance printing plate | EASTMAN KODAK COMPANY (US) | 2005-11-29 | — | — | US | disclosed |
| EP-0146326-B1 | SULFOPOLYESTER-CONTAINING PHOTOPOLYMER SYSTEMS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-03-13 | — | — | EP | disclosed |
| US-4956265-A | POLYUNSATURATED WITH ESTER AND CARBOXY GROUPS; PROTECTIVE COATINGS, GRAPHIC ARTS, PHOTORESTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-09-11 | — | — | US | disclosed |
| US-4914165-A | PHOTOCROSSLINKABLE POLYEPOXIDE POLYESTERS USING POLY (ETHYLENICALLY-UNSATURATED)ALKANOLS AND DICARBOXYLIC ACIDS; PROTECTIVE COATINGS; GRAPHIC ARTS; WEAR RESISTANCE; ADHESION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0329298-A2 | Radiation crosslinkable compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-08-23 | — | — | EP | disclosed |
| US-4855384-A | POLYURETHANES FROM POLYESTERS OR POLY OF SULFOAROMATIC DICARBOCYLIC ACIDS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-08-08 | — | — | US | disclosed |
| US-4746717-A | COATINGS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-05-24 | — | — | US | disclosed |
| US-4558149-A | FILMS;COATINGS;PHOTORESISTS;LOW MOLECULAR WEIGHT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-12-10 | — | — | US | disclosed |
| EP-0146326-A2 | Sulfopolyester-containing photopolymer systems | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11617814-B2 | Methods of treatment comprising administering polymer particles configured for intravascular delivery of pharmaceutical agents | PLG, LPXN, PLAU | KEAP1 3292/4885NFE2L2 4565/4885KDM4E 4482/4885 |
| US-12447228-B2 | Polymer particles | PCBP1, LCP1, PSAP | KEAP1 4606/4885NFE2L2 4692/4885KDM4E 4411/4885 |
| US-10729805-B2 | Drug delivery polymer particles with hydrolytically degradable linkages | MMP1, GUSB, PRCP | KEAP1 3779/4885NFE2L2 4567/4885KDM4E 3543/4885 |
| US-20190255213-A1 | POLYMER PARTICLES | PCBP1, LCP1, PSAP | KEAP1 4605/4885NFE2L2 4692/4885KDM4E 4411/4885 |
| US-10328175-B2 | Polymer particles | PCBP1, LCP1, PSAP | KEAP1 4606/4885NFE2L2 4692/4885KDM4E 4411/4885 |
| US-20200324016-A1 | POLYMER PARTICLES | PCBP1, LCP1, PSAP | KEAP1 4606/4885NFE2L2 4692/4885KDM4E 4411/4885 |
| US-20230190991-A1 | POLYMER PARTICLES | PCBP1, LCP1, PSAP | KEAP1 4606/4885NFE2L2 4692/4885KDM4E 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.